Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites. 2017

Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
Department of Physiology and Pharmacology (L.C.B., T.P, K.E., S.L.-K., A.A.I., B.M.K., J.E.O., C.E.B., A.C.H.) and Department of Biochemistry and Center for Structural Biology (R.R.H., W.T.L.), Wake Forest University Health Sciences, Winston-Salem, North Carolina; Department of Chemistry (T.P.) and Center for Molecular Signaling (W.T.L., A.C.H.), Wake Forest University, Winston-Salem, North Carolina; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (D.E.S.); and AL Azhar Faculty of Medicine, New Damietta, Egypt (K.E.).

Cannabinoid receptor interacting protein 1a (CRIP1a) is a CB1 receptor (CB1R) distal C-terminal-associated protein that alters CB1R interactions with G-proteins. We tested the hypothesis that CRIP1a is capable of also altering CB1R interactions with β-arrestin proteins that interact with the CB1R at the C-terminus. Coimmunoprecipitation studies indicated that CB1R associates in complexes with either CRIP1a or β-arrestin, but CRIP1a and β-arrestin fail to coimmunoprecipitate with each other. This suggests a competition for CRIP1a and β-arrestin binding to the CB1R, which we hypothesized could attenuate the action of β-arrestin to mediate CB1R internalization. We determined that agonist-mediated reduction of the density of cell surface endogenously expressed CB1Rs was clathrin and dynamin dependent and could be modeled as agonist-induced aggregation of transiently expressed GFP-CB1R. CRIP1a overexpression attenuated CP55940-mediated GFP-CB1R as well as endogenous β-arrestin redistribution to punctae, and conversely, CRIP1a knockdown augmented β-arrestin redistribution to punctae. Peptides mimicking the CB1R C-terminus could bind to both CRIP1a in cell extracts as well as purified recombinant CRIP1a. Affinity pull-down studies revealed that phosphorylation at threonine-468 of a CB1R distal C-terminus 14-mer peptide reduced CB1R-CRIP1a association. Coimmunoprecipitation of CB1R protein complexes demonstrated that central or distal C-terminal peptides competed for the CB1R association with CRIP1a, but that a phosphorylated central C-terminal peptide competed for association with β-arrestin 1, and phosphorylated central or distal C-terminal peptides competed for association with β-arrestin 2. Thus, CRIP1a can compete with β-arrestins for interaction with C-terminal CB1R domains that could affect agonist-driven, β-arrestin-mediated internalization of the CB1R.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071557 beta-Arrestins Non-visual system arrestins that negatively regulate G-PROTEIN-COUPLED RECEPTORS (GPCRs) and may also function independently of GPCR signaling. They bind and recruit many different signaling factors, including MITOGEN-ACTIVATED PROTEIN KINASES; SRC-FAMILY-KINASES; and FILAMIN to GPCRs and may recognize different phosphorylation states of the receptors to determine the specificity of the cellular response to signaling. beta-Arrestin,beta Arrestin,beta Arrestins
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D043884 Receptor, Cannabinoid, CB1 A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release. Cannabinoid Receptor CB1,CB1 Receptor,Receptor CB1, Cannabinoid,Receptor, CB1

Related Publications

Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
April 2015, Molecular pharmacology,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
June 2022, Cannabis and cannabinoid research,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
December 2007, Molecular pharmacology,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
February 2024, Protein & cell,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
October 2023, Cannabis and cannabinoid research,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
October 2017, Journal of molecular graphics & modelling,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
October 2019, Molecules (Basel, Switzerland),
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
May 2016, Brain structure & function,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
November 2020, Biomolecules,
Lawrence C Blume, and Theresa Patten, and Khalil Eldeeb, and Sandra Leone-Kabler, and Alexander A Ilyasov, and Bradley M Keegan, and Jeremy E O'Neal, and Caroline E Bass, and Roy R Hantgan, and W Todd Lowther, and Dana E Selley, and A Llyn C Howlett
February 2023, British journal of pharmacology,
Copied contents to your clipboard!